Literature DB >> 9714262

Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms.

D A Gilbert1, K Z Altshuler, W V Rago, S P Shon, M L Crismon, M G Toprac, A J Rush.   

Abstract

BACKGROUND: The Texas Medication Algorithm Project (TMAP), a public-academic collaborative effort, is a 3-phase project to develop, implement, and evaluate medication treatment algorithms for public sector patients with schizophrenia, major depressive disorders, or bipolar disorders. DISCUSSION: This paper, the first in a series describing the activities of the TMAP, focuses on the various definitions and reasons why guidelines have gained popularity. Also discussed are their strengths, the limitations of the various methods used to develop them, and potential barriers to their implementation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714262

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  14 in total

1.  Guidelines for treatment of bipolar disorder.

Authors:  E B Dennehy
Journal:  Curr Psychiatry Rep       Date:  2000-08       Impact factor: 5.285

Review 2.  [Therapy resistance to antidepressants. Definition, prevalence, predictors, and interventional possibilities].

Authors:  H-J Möller
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

3.  Evidence-based practices in community mental health: outcome evaluation.

Authors:  Kirstin Painter
Journal:  J Behav Health Serv Res       Date:  2012-10       Impact factor: 1.505

Review 4.  Diagnosing schizophrenia circa 2005: how and why?

Authors:  Laurie M McCormick; Michael Flaum
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

5.  Manufacturing consensus.

Authors:  David Healy
Journal:  Cult Med Psychiatry       Date:  2006-06

Review 6.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Authors:  Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

Review 7.  Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.

Authors:  Konstantinos N Fountoulakis; Siegfried Kasper; Ole Andreassen; Pierre Blier; Ahmed Okasha; Emanuel Severus; Marcio Versiani; Rajiv Tandon; Hans-Jürgen Möller; Eduard Vieta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06       Impact factor: 5.270

8.  Itemized clinician ratings versus global ratings of symptom severity in patients with schizophrenia.

Authors:  Kathy Shores-Wilson; Melanie M Biggs; Alexander L Miller; Thomas J Carmody; John A Chiles; A John Rush; M Lynn Crismon; Marcia G Toprac; Bradley P Witte; Joe C Webster
Journal:  Int J Methods Psychiatr Res       Date:  2002       Impact factor: 4.035

9.  Translating Science Into Service: Lessons Learned From the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study.

Authors:  Norman Sussman
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

10.  A psychometric evaluation of the clinician-rated Quick Inventory of Depressive Symptomatology (QIDS-C16) in patients with bipolar disorder.

Authors:  Ira H Bernstein; A John Rush; Trisha Suppes; Madhukar H Trivedi; Ada Woo; Yasushi Kyutoku; M Lynn Crismon; Ellen Dennehy; Thomas J Carmody
Journal:  Int J Methods Psychiatr Res       Date:  2009-06       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.